Skip to main content

Table 3 Distribution of imipenem MIC for P. aeruginosa isolates from the SMART global surveillance programa

From: In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

 

MIC μg/mL, n (cumulative %)

MIC90

≤0.06

0.125

0.25

0.5

1

2

4

8

16

≥32

SMART 2009

(n = 993 isolates)

IMI

0

4 (0.4)

12 (1.6)

159 (17.6)

308 (48.6)

196 (68.4)

38 (72.2)

26 (74.8)

100 (84.9)

96 (94.6)

≥32

IMI/RELb

0

14 (1.4)

380 (39.7)

306 (70.5)

78 (78.3)

92 (87.6)

46 (92.2)

18 (94.1)

10 (95.1)

10 (96.1)

4

SMART 2011

(n = 1702 isolates)

IMI

3 (0.2)

4 (0.4)

15 (1.3)

92 (6.7)

596 (41.7)

437 (67.4)

109 (73.8)

73 (78.1)

162 (87.6)

123 (94.8)

≥32

IMI/RELb

5 (0.3)

9 (0.8)

216 (13.5)

883 (65.4)

207 (77.6)

143 (86.0)

108 (92.3)

37 (94.5)

13 (95.2)

13 (96.0)

4

SMART 2015

(n = 5953 isolates)

IMI

NDc

NDc

NDc

1035 (17.4)d

2617 (61.3)

540 (70.4)

246 (74.6)

579 (84.3)

565 (93.8)

371 (100.0)

16

IMI/RELb

58 (1.0)

214 (4.6)

2120 (41.7)

1934 (74.2)

587 (84.0)

453 (91.7)

152 (94.2)

111 (96.1)

53 (97.0)

181 (100.0)

2

SMART 2016

(n = 6165 isolates)

IMI

NDc

NDc

NDc

925 (15.0)d

2593 (57.1)

634 (67.3)

278 (71.9)

567 (81.1)

671 (91.9)

497 (100.0)

16

IMI/RELb

49 (0.8)

169 (3.5)

1875 (33.9)

2299 (71.2)

564 (80.4)

586 (89.9)

154 (92.4)

92 (93.9)

68 (95.0)

309 (100.0)

4

  1. IMI imipenem, IMI/REL imipenem/relebactam, MIC minimum inhibitory concentration, ND not determined
  2. aIncludes SMART surveillance data through October 2018
  3. bImipenem combined with 4 μg/mL of relebactam
  4. cThis MIC value was not tested
  5. dThis value is for ≥0.5 μg/mL, since MIC values < 0.5 μg/mL were not tested